2,6,9-trisubstituted purines: Optimization towards highly potent and selective CDK1 inhibitors

被引:93
作者
Imbach, P [1 ]
Capraro, HG [1 ]
Furet, P [1 ]
Mett, H [1 ]
Meyer, T [1 ]
Zimmermann, J [1 ]
机构
[1] Novartis Ltd, Therapeut Area Oncol, Novartis Pharmaceut, CH-4002 Basel, Switzerland
关键词
D O I
10.1016/S0960-894X(98)00691-X
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Novel 2,6,9-substituted purine derivatives represent a class of potent and selective inhibitors of CDK1/cyclinB. The synthesis, SAR and biological profile of selected compounds are described, (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:91 / 96
页数:6
相关论文
共 29 条
[11]   Combinatorial synthesis of 2,9-substituted purines. [J].
Gray, NS ;
Kwon, S ;
Schultz, PG .
TETRAHEDRON LETTERS, 1997, 38 (07) :1161-1164
[12]   CELL-CYCLE REGULATION OF CDK2 ACTIVITY BY PHOSPHORYLATION OF THR160 AND TYR15 [J].
GU, Y ;
ROSENBLATT, J ;
MORGAN, DO .
EMBO JOURNAL, 1992, 11 (11) :3995-4005
[13]   INHIBITION OF CDK2 ACTIVITY IN-VIVO BY AN ASSOCIATED 20K REGULATORY SUBUNIT [J].
GU, Y ;
TURCK, CW ;
MORGAN, DO .
NATURE, 1993, 366 (6456) :707-710
[14]   Cytokinin-derived cyclin-dependent kinase inhibitors: Synthesis and cdc2 inhibitory activity of olomoucine and related compounds [J].
Havlicek, L ;
Hanus, J ;
Vesely, J ;
Leclerc, S ;
Meijer, L ;
Shaw, G ;
Strnad, M .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (04) :408-412
[15]   Maturation promoting factor, cyclin and the control of M-phase [J].
Hunt, T. .
CURRENT OPINION IN CELL BIOLOGY, 1989, 1 (02) :268-274
[16]  
KITAGAWA M, 1993, ONCOGENE, V8, P2425
[17]   STUDIES ON THE ALKYLATION OF DERIVATIVES OF GUANINE [J].
KJELLBERG, J ;
JOHANSSON, NG .
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 1989, 8 (02) :225-256
[18]   Synthesis of C2 alkynylated purines, a new family of potent inhibitors of cyclin-dependent kinases [J].
Legraverend, M ;
Ludwig, O ;
Bisagni, E ;
Leclerc, S ;
Meijer, L .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (07) :793-798
[19]   Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5 [J].
Meijer, L ;
Borgne, A ;
Mulner, O ;
Chong, JPJ ;
Blow, JJ ;
Inagaki, N ;
Inagaki, M ;
Delcros, JG ;
Moulinoux, JP .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 243 (1-2) :527-536
[20]   CYCLIN IS A COMPONENT OF THE SEA-URCHIN EGG M-PHASE SPECIFIC HISTONE H-1 KINASE [J].
MEIJER, L ;
ARION, D ;
GOLSTEYN, R ;
PINES, J ;
BRIZUELA, L ;
HUNT, T ;
BEACH, D .
EMBO JOURNAL, 1989, 8 (08) :2275-2282